BF-1

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBF-1

Drug Alias NameBF-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists

TargetsSerotonin 2b (5-HT2b) receptor

Therapy Area/IndicationsMigraine Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiofrontera Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiofrontera Inc

Active IndicationsN/A

Inactive IndicationsMigraine Disorders

ATC CodeN/A